Biocon Biologics said that it has entered into a long-term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.Shares of Biocon fell over 4 percent on March 15 after its subsidiary Biocon Biologics' India-branded formulation business was acquired by Eris Lifesciences, a chronic therapy-focused drug f...

Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in AustraliaThe agreement provides Sandoz the exclusive rights to promote, sell and distribute biosimilars Trastuzumab and Bevacizumab in Australia, Biocon Biologics said in a statement.Biocon Biologics on Friday said it has inked a five-year pact with pharmaceutical company Sandoz AG regarding the sale and distribution of tw...

The domestic indices were trading broadly lower on Thursday. NSE Nifty touched the day’s low falling 97.75 pts or 0.55% to 17,797.95. The BSE Sensex dropped 364.28 or 0.61% to 59,741.22. Most of the broader market indices were trading in red with Bank Nifty falling over half a percent. Reliance Industries Ltd (RIL), Bajaj Finance, Bharti Airtel, ICICI Bank and Axis Bank were the most active equi...

The Securities Appellate Tribunal (SAT) has quashed the charges of insider trading in Biocon against Shreehas Tambe, president and deputy CEO of Biocon Biologics.Sebi had passed an order restraining Tambe from accessing the securities market for a period of three months and also restraining him from associating with any listed public company or any public company for a period of three months. The ...

Here is the list of top 10 stocks that will be in focus todayTata Motors: Tata Motors on Wednesday reported a consolidated net loss of Rs4,951 crore in the June quarter as chip shortage and COVID-19 lockdown in China impacted Jaguar Land Rover sales. The company had posted a consolidated net loss of Rs4,450 crore in the same quarter last fiscal. Consolidated revenue from operations during the peri...